Melody Transcatheter Pulmonary Valve
Medtronic, Inc. · Decision date Oct 23, 2025
What did the FDA decide?
FDA records P140017/S032 as a supplement to PMA P140017, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Oct 23, 2025.
FDA approval order statement
modifications to the ethylene oxide sterilization cycle and additional sterilizers for the sub-tier supplier of sterile sutures used in valve assembly
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 23, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P140017/S032
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic, Inc.
- Product code
- NPV
- Decision code
- OK30
- Decision date
- Oct 23, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Pulmonary valve prosthesis percutaneously delivered.
- Applicant
- Medtronic, Inc.
- Product code
- NPV
- FDA device class
- f
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P140017/S031 · Related supplement
Melody Transcatheter Pumonary Valve System
P140017/S032 received
Application receipt date recorded by FDA.
P140017/S032 · FDA decision
30-Day Notice
P140017/S033 · Related supplement
Melody Transcatheter Pulmonary Valve
P140017/S034 · Related supplement
Melody Transcatheter Pulmonary Valve
P140017/S036 · Related supplement
Melody Transcatheter Pulmonary Valve
P140017/S035 · Related supplement
Melody Transcatheter Pulmonary Valve System, which includes the Melody Transcatheter Pulmonary Valve (Melody TPV) and th
Timeline entries are records held by MedtechLedger for P140017. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P140017
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Melody Transcatheter Pumonary Valve SystemP140017/S031 | Medtronic, Inc. | PMA supplement | Aug 21, 2025 | FDA |
Melody Transcatheter Pulmonary ValveP140017/S033 | Medtronic, Inc. | PMA supplement | Feb 12, 2026 | FDA |
Melody Transcatheter Pulmonary ValveP140017/S034 | Medtronic, Inc. | PMA supplement | Apr 9, 2026 | FDA |
Melody Transcatheter Pulmonary ValveP140017/S036 | Medtronic, Inc. | PMA supplement | Jun 1, 2026 | FDA |
| Medtronic, Inc. | PMA supplement | Jun 9, 2026 | FDA |
Explore the linked device profile
Other records with product code NPV
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 27, 2026 | FDA | |
Harmony TPV SystemP200046/S052 | Medtronic, Inc. | PMA supplement | Sep 30, 2026 | FDA |
| Edwards Lifesciences, LLC | PMA supplement | Sep 23, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Jul 29, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 8200 Coral Sea St. NE Mvs83, Mounds View, MN, 55112
Sources and methodology
- Original FDA record: P140017/S032
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


